COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.
Facial Injectables are the face skin fillers that are used in many applications like dark circles removal, uplifting of eyebrows, thinning of the lips, enhancement of cheekbones and others applications.Facial injectable are also used to reduce wrinkles and smoothen skin appearance caused by ageing, acne or scars. The major application areas are face including nasolabial fold, cheeks, lips, corners of the eye and for enhancing appearance of dorsal area of hands. There are two major types of facial Injectable namely botulinum toxin and dermal fillers. Some of the key commercially available botulinum toxin brands include Dysport, Xeomin, Meditoxin, Botulax and Nabota. Dermal fillers may be of Hyaluronic acid based, Calcium Hydroxyapatite based, Poly-Lactic acid based, collagen based or Polymethylmethacrylate-based (non-absorbable).
Fig 1: CEE FACIAL INJECTABLES MARKET, BY SEGMENTATION
The key factors for the growth of the facial injectables market in CEE region include the rising aesthetic consciousness and number of cosmetic procedures, the introduction of cost-effective facial injectable, and the aging population. As the cosmetic industry is booming, there has been an increase in the total number of non-surgical therapies, such as injections of wrinkle relaxers and dermal fillers. This trend is primarily due to the advantages of technologies, such as low recovery time, less risk of infections, no blood loss, and the overall reduction in procedural costs. Thus, the increase in the number of cosmetic procedures has spurred the growth of the overall market. In addition, there is a consistent rise in the geriatric population that helps to boost the market growth. Along with the aging population, the new generation has been attracted to the cosmetic industry to appear more youthful. Furthermore, technological advancements are also helping in the growth of the market. However, strict regulatory concerns of injectable products and side effects of such products such as rashes restrict market growth.
The CEE facial injectables market is segmented into two major market segments, namely; by product and by end user.
Fig 2: CEE FACIAL INJECTABLES MARKET, BY PRODUCT
The product segment includes dermal fillers/injectable implants, and anti-aging/ anti-wrinkle injections. The dermal fillers segment is expacted to dominate the CEE facial injectables market in 2020. Dermal fillers segment is further categorized into hyaluronic acid fillers, collagen fillers and synthetic fillers while anti-ageing injections are divided into botulinum toxin A and poly-L-lactic acid (PLLA) micro particles. The hyaluronic acid segment dominated the market in 2019 and is expected to witness lucrative growth over the forecast period. Increasing application of hyaluronic acid in cosmetic industry is expected to support the growth. Hyaluronic acid was first used in medicine in mid 1980s. Currently, HA is the world’s most frequently used filler. It is among the natural chemical substances found in the skin and serves as a major structural component of extracellular space. When used in aesthetic medicine, hyaluronic acid is cross-linked which means it is subjected to a process aimed at prolonging its residence time in tissue. Hyaluronic acid obtained by bio-technology is characterized by a high purity and very good biocompatability. The European Commission considers fillers to be medical devices, and it is easier to obtain a CE mark than FDA (Food and Drug Administration) approval. Many of the Central and Eastern European countries have high-cohesivity HAs, as well as very low-cohesivity HAs, that are not available in the United States.
Fig 3: CEE FACIAL INJECTABLES MARKET, BY END USER
The end user segment includes hospitals, dermatology clinics, beauty clinics, and dermatology research institute. The hospitals segment is expected to hold the largest market share in 2020 as the number of hospitals and the flow of patients in hospital establishment is increasing at an exponential rate. With growing population across the nations, the demand for hospitals and relaiable healthcare in rapidly increasing. Growing number of hospitals and increasing inflow of patients in the hospital establishments is the primary factor driving the growth of facial injectables market in hospitals in the CEE region. In 2017, there were 1,058 hospitals in Poland. The number of hospitals in Poland has generally increased since the year 2000, when there were approximately 800 hospitals in the country. Also, in Bulgaria there were 322 hospitals in 2018, compared to the 312 that were recorded in 2010. Many of these hospitals have a separate aesthetic department that focuses on treatments for the face, maintain skin and add volume and shape to the skin, thus drives the demand for facial injectable products. However, dermatology clinics segment is expected to witness fastest growth during the forecast period.
Fig 4: CEE FACIAL INJECTABLES MARKET, BY COUNTRY
On the basis of the country the CEE facial injectable market is segmented into Poland, CZECH Republic, Croatia, Bulgaria, Romania, Hungary, Slovakia, Estonia, Latvia, Slovenia, and Lithuania. In 2020, Poland is expected to dominate the CEE facial injectable market and is also expected to maintain its dominance during the forecast period. Factors such as increasing healthcare expenditure, growing investments in the dermatological and cosmetic surgery field, increasing adoption of plastic surgery and growing skin care techniques are driving the growth of the market in Poland. Furthermore, growing government investments in development of healthcare infrastructure and increasing implementation o advanced technologies are also fueling the growth of this regional segment.
Fig 5: CEE FACIAL INJECTABLE MARKET SEGMENT OUTLOOK
Companies Covered: Allergan Plc, Merz Inc, Galderma Laboratories, Colbar Lifescience Ltd, Sanofi Biosurgery Inc, Anika Therapeutics, Inc, Prollelium Medical Technologies Inc, Suneva Medical Inc, Zimmer Biomet, Sinclair Pharma, Sculpt Luxury Dermal Fillers Ltd, Bioxis Pharmaceuticals, Scivision Biotech Inc.
Market Segments
By Product
By End User
Country Analysis CEE Facial Injectables Market
Reasons To Buy This Report:
Customization:
We provide customization of the study to meet specific requirements:
For more information, contact: [email protected]
Table Of Contents
1 Market Abstract
2 Market Introduction
2.1 Market Scope
3 QMI Research Practice
3.1 Research Practice
3.1.1 Supply Based Analysis
3.1.2 Demand Based Analysis
3.1.3 Global Level Analysis
3.1.4 Country Level Analysis
3.1.5 Triangulation
3.2 Primary Data
3.3 Secondary Data
3.4 Market Evaluation & Forecasting Methodology
3.5 Assumptions/ Limitations For The Study
3.6 What This Study Provides
3.7 Key Questions Answered By This Report
3.8 This Study Is Intended For
4 Key Related Data
4.1 Competitive Positioning
4.1.1 Product Positioning
4.1.2 Revenue Positioning
4.1.3 Regional Reach Positioning
4.2 Cee Healthcare Sector Data
4.3 Major Investments In Last Five Years By Global Players
4.4 Guidelines & Regulations
4.5 Key Industry Trends
4.6 Technological Advancement In Filler And Injectable Devices In Cee Region
5 Impact Factor Analysis
5.1 Micro Economic Pointers
5.1.1 Research And Development Investment By Company
5.2 Macro Economic Pointers
5.2.1 Number Of Hospitals, By Country
5.2.2 Population, By Country
5.3 Porter’s Five Forces Model
6 Market Development Analysis
6.1 Overview
6.2 New Product Development, Launch And Approval (2016-2020)
6.3 Agreement, Partnership & Collaboration (2016-2020)
6.4 Merger & Acquisitions (2016-2020)
6.5 Expansions (2016-2020)
6.6 Others (2016-2020)
7 CEE Facial Injectable Market, By Product
7.1 Introduction
7.2 Dermal Fillers/Injectable Implants
7.2.1 Hyaluronic Acid Fillers
7.2.2 Collagen Fillers
7.2.3 Synthetic Fillers
7.3 Anti-Aging/ Anti-Wrinkle Injections
7.3.1 Botulinum Toxin A
7.3.2 Poly-L-Lactic Acid (Plla) Micro Particles
8 CEE Facial Injectable Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Dermatology Clinics
8.4 Beauty Clinics
8.5 Dermatology Research Institutes
9 CEE Facial Injectable Market, Country Analysis
9.1 Introduction
9.2 Poland
9.3 Czech Republic
9.4 Bulgaria
9.5 Croatia
9.6 Slovakia
9.7 Romania
9.8 Estonia
9.9 Latvia
9.10 Hungary
9.11 Slovenia
9.12 Lithuania
10 Company Profile
10.1 Allergan Plc
10.1.1 Company Overview
10.1.2 Allergan Plc: Financial Overview
10.1.3 Allergan Plc: Product Overview
10.1.4 Allergan Plc: Swot Analysis
10.1.5 Allergan Plc: Key Developments (2017-2020)
10.2 Merz Inc.
10.2.1 Company Overview
10.2.2 Merz Inc.: Financial Overview
10.2.3 Merz Inc.: Product Overview
10.2.4 Merz Inc.: Swot Analysis
10.2.5 Merz Inc.: Key Developments (2016-2020)
10.3 Galderma Laboratories
10.3.1 Company Overview
10.3.2 Galderma Laboratories: Product Overview
10.3.3 Galderma Laboratories: Swot Analysis
10.3.4 Galderma Laboratories: Key Developments (2017-2020)
10.4 Colbar Lifescience Ltd.
10.4.1 Company Overview
10.4.2 Colbar Lifescience Ltd: Product Overview
10.4.3 Colbar Lifescience Ltd: Key Developments (2017-2020)
10.5 Sanofi Biosurgery Inc.
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Sanofi Biosurgery Inc.: Product Overview
10.5.4 Sanofi: Swot Analysis
10.5.5 Sanofi Biosurgery Inc.: Key Developments (2017-2020)
10.6 Anika Therapeutics, Inc.
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Anika Therapeutics: Product Overview
10.6.4 Anika Therapeutics: Swot Analysis
10.6.5 Anika Therapeutics: Key Developments (2017-2020)
10.7 Teoxane Laboratories
10.7.1 Company Overview
10.7.2 Teoxane Laboratories: Product Overview
10.7.3 Teoxane Laboratories: Swot Analysis
10.7.4 Teoxane Laboratories: Key Developments (2017-2020)
10.8 Prollelium Medical Technologies Inc.
10.8.1 Company Overview
10.8.2 Prollelium Medical Technologies Inc.: Product Overview
10.8.3 Prollelium Medical Technologies Inc.: Swot Analysis
10.8.4 Prollelium Medical Technologies Inc.: Key Developments (2017-2020)
10.9 Suneva Medical Inc.
10.9.1 Company Overview
10.9.2 Suneva Medical Inc.: Product Overview
10.9.3 Suneva Medical Inc.: Swot Analysis
10.9.4 Suneva Medical Inc.: Key Developments (2017-2020)
10.10 Zimmer Biomet
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Zimmer Biomet: Product Overview
10.10.4 Zimmer Biomet: Swot Analysis
10.10.5 Zimmer Biomet: Key Developments (2017-2020)
10.11 Sinclair Pharma
10.11.1 Company Overview
10.11.2 Sinclair Pharma: Product Overview
10.11.3 Sinclair Pharma: Swot Analysis
10.11.4 Sinclair Pharma: Key Developments (2017-2020)
10.12 Sculpt Luxury Dermal Fillers Ltd
10.12.1 Company Overview
10.12.2 Sculpt Luxury Dermal Fillers Ltd: Product Overview
10.12.3 Sculpt Luxury Dermal Fillers Ltd: Key Developments (2017-2020)
10.13 Bioxis Pharmaceuticals
10.13.1 Company Overview
10.13.2 Bioxis Pharmaceuticals: Product Overview
10.13.3 Bioxis Pharmaceuticals: Key Developments (2017-2020)
10.14 Scivision Biotech Inc
10.14.1 Company Overview
10.14.2 Financial Overview
10.14.3 Scivision Biotech Inc: Product Overview
10.14.4 Scivision Biotech Inc: Key Developments (2017-2020)
11 Appendix
11.1 List Of Abbreviation
11.2 Key Related Reports
LIST OF TABLES
TABLE 1 NEW PRODUCT DEVELOPMENT, LAUNCH AND APPROVAL (2016-2020)
TABLE 2 AGREEMENT, PARTNERSHIP & COLLABORATION (2016-2020)
TABLE 3 MERGER & ACQUISITIONS (2016-2020)
TABLE 4 EXPANSIONS (2016-2020)
TABLE 5 OTHERS (2016-2020)
TABLE 6 CEE FACIAL INJECTABLE MARKET, BY PRODUCT (USD MILLION)
TABLE 7 CEE DERMAL FILLERS/INJECTABLE IMPLANTS MARKET, BY TYPE (USD MILLION)
TABLE 8 CEE DERMAL FILLERS/INJECTABLE IMPLANTS MARKET, BY COUNTRY (USD MILLION)
TABLE 9 HYALURONIC ACID FILLERS MARKET – BY COUNTRY (USD MILLION)
TABLE 10 COLLAGEN FILLERS MARKET, BY COUNTRY (USD MILLION)
TABLE 11 SYNTHETIC FILLERS MARKET, BY COUNTRY (USD MILLION)
TABLE 12 ANTI-AGING/ ANTI-WRINKLE INJECTIONS MARKET, BY TYPE (USD MILLION)
TABLE 13 ANTI-AGING/ ANTI-WRINKLE INJECTIONS MARKET, BY COUNTRY (USD MILLION)
TABLE 14 BOTULINUM TOXIN A MARKET – BY COUNTRY (USD MILLION)
TABLE 15 POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES MARKET, BY COUNTRY (USD MILLION)
TABLE 16 CEE FACIAL INJECTABLE MARKET, BY END USER (USD MILLION)
TABLE 17 FACIAL INJECTABLE MARKET IN HOSPITALS, BY COUNTRY (USD MILLION)
TABLE 18 FACIAL INJECTABLE MARKET IN DERMATOLOGY CLINICS – BY COUNTRY (USD MILLION)
TABLE 19 FACIAL INJECTABLE MARKET FOR BEAUTY CLINICS, BY COUNTRY (USD MILLION)
TABLE 20 FACIAL INJECTABLE MARKET FOR DERMATOLOGY RESEARCH INSTITUTES, BY COUNTRY (USD MILLION)
TABLE 21 CEE FACIAL INJECTABLE MARKET, BY COUNTRY (USD MILLION)
TABLE 22 POLAND FACIAL INJECTABLE MARKET, BY PRODUCT (USD MILLION)
TABLE 23 POLAND DERMAL FILLERS/ INJECTABLE IMPLANTS MARKET, BY TYPE (USD MILLION)
TABLE 24 POLAND ANTI-AGING/ ANTI-WRINKLE INJECTIONS MARKET, BY TYPE (USD MILLION)
TABLE 25 POLAND FACIAL INJECTABLE MARKET, BY END USER (USD MILLION)
TABLE 26 CZECH REPUBLIC FACIAL INJECTABLE MARKET, BY PRODUCT (USD MILLION)
TABLE 27 CZECH REPUBLIC DERMAL FILLERS/ INJECTABLE IMPLANTS MARKET, BY TYPE (USD MILLION)
TABLE 28 CZECH REPUBLIC ANTI-AGING/ ANTI-WRINKLE INJECTIONS MARKET, BY TYPE (USD MILLION)
TABLE 29 CZECH REPUBLIC FACIAL INJECTABLE MARKET, BY END USER (USD MILLION)
TABLE 30 BULGARIA FACIAL INJECTABLE MARKET, BY PRODUCT (USD MILLION)
TABLE 31 BULGARIA DERMAL FILLERS/ INJECTABLE IMPLANTS MARKET, BY TYPE (USD MILLION)
TABLE 32 BULGARIA ANTI-AGING/ ANTI-WRINKLE INJECTIONS MARKET, BY TYPE (USD MILLION)
TABLE 33 BULGARIA FACIAL INJECTABLE MARKET, BY END USER (USD MILLION)
TABLE 34 CROATIA FACIAL INJECTABLE MARKET, BY PRODUCT (USD MILLION)
TABLE 35 CROATIA DERMAL FILLERS/ INJECTABLE IMPLANTS MARKET, BY TYPE (USD MILLION)
TABLE 36 CROATIA ANTI-AGING/ ANTI-WRINKLE INJECTIONS MARKET, BY TYPE (USD MILLION)
TABLE 37 CROATIA FACIAL INJECTABLE MARKET, BY END USER (USD MILLION)
TABLE 38 SLOVAKIA FACIAL INJECTABLE MARKET, BY PRODUCT (USD MILLION)
TABLE 39 SLOVAKIA DERMAL FILLERS/ INJECTABLE IMPLANTS MARKET, BY TYPE (USD MILLION)
TABLE 40 SLOVAKIA ANTI-AGING/ ANTI-WRINKLE INJECTIONS MARKET, BY TYPE (USD MILLION)
TABLE 41 SLOVAKIA FACIAL INJECTABLE MARKET, BY END USER (USD MILLION)
TABLE 42 ROMANIA FACIAL INJECTABLE MARKET, BY PRODUCT (USD MILLION)
TABLE 43 ROMANIA DERMAL FILLERS/ INJECTABLE IMPLANTS MARKET, BY TYPE (USD MILLION)
TABLE 44 ROMANIA ANTI-AGING/ ANTI-WRINKLE INJECTIONS MARKET, BY TYPE (USD MILLION)
TABLE 45 ROMANIA FACIAL INJECTABLE MARKET, BY END USER (USD MILLION)
TABLE 46 ESTONIA FACIAL INJECTABLE MARKET, BY PRODUCT (USD MILLION)
TABLE 47 ESTONIA DERMAL FILLERS/ INJECTABLE IMPLANTS MARKET, BY TYPE (USD MILLION)
TABLE 48 ESTONIA ANTI-AGING/ ANTI-WRINKLE INJECTIONS MARKET, BY TYPE (USD MILLION)
TABLE 49 ESTONIA FACIAL INJECTABLE MARKET, BY END USER (USD MILLION)
TABLE 50 LATVIA FACIAL INJECTABLE MARKET, BY PRODUCT (USD MILLION)
TABLE 51 LATVIA DERMAL FILLERS/ INJECTABLE IMPLANTS MARKET, BY TYPE (USD MILLION)
TABLE 52 LATVIA ANTI-AGING/ ANTI-WRINKLE INJECTIONS MARKET, BY TYPE (USD MILLION)
TABLE 53 LATVIA FACIAL INJECTABLE MARKET, BY END USER (USD MILLION)
TABLE 54 HUNGARY FACIAL INJECTABLE MARKET, BY PRODUCT (USD MILLION)
TABLE 55 HUNGARY DERMAL FILLERS/ INJECTABLE IMPLANTS MARKET, BY TYPE (USD MILLION)
TABLE 56 HUNGARY ANTI-AGING/ ANTI-WRINKLE INJECTIONS MARKET, BY TYPE (USD MILLION)
TABLE 57 HUNGARY FACIAL INJECTABLE MARKET, BY END USER (USD MILLION)
TABLE 58 SLOVENIA FACIAL INJECTABLE MARKET, BY PRODUCT (USD MILLION)
TABLE 59 SLOVENIA DERMAL FILLERS/ INJECTABLE IMPLANTS MARKET, BY TYPE (USD MILLION)
TABLE 60 SLOVENIA ANTI-AGING/ ANTI-WRINKLE INJECTIONS MARKET, BY TYPE (USD MILLION)
TABLE 61 SLOVENIA FACIAL INJECTABLE MARKET, BY END USER (USD MILLION)
TABLE 62 LITHUANIA FACIAL INJECTABLE MARKET, BY PRODUCT (USD MILLION)
TABLE 63 LITHUANIA DERMAL FILLERS/ INJECTABLE IMPLANTS MARKET, BY TYPE (USD MILLION)
TABLE 64 LITHUANIA ANTI-AGING/ ANTI-WRINKLE INJECTIONS MARKET, BY TYPE (USD MILLION)
TABLE 65 LITHUANIA FACIAL INJECTABLE MARKET, BY END USER (USD MILLION)
LIST OF FIGURES
FIGURE 1 CEE FACIAL INJECTABLES MARKET, BY PRODUCT
FIGURE 2 CEE FACIAL INJECTABLES MARKET, BY END USER
FIGURE 3 CEE FACIAL INJECTABLES MARKET, BY COUNTRY
FIGURE 4 CEE FACIAL INJECTABLE MARKET – MARKET SCOPE
FIGURE 5 CEE FACIAL INJECTABLE MARKET –RESEARCH PRACTICE
FIGURE 6 CEE FACIAL INJECTABLE MARKET –RESEARCH METHODOLOGY
FIGURE 7 CEE FACIAL INJECTABLE MARKET –PRIMARY AND SECONDARY RESEARCH
FIGURE 8 CEE: HEALTHCARE SPENDING AS PERCENTAGE OF GDP
FIGURE 9 CEE AND NEARBY EMERGING MARKETS ATTRACTING MOST PRIVATE INVESTMENT IN HEALTHCARE
FIGURE 10 PORTER’S FIVE FORCES MODEL- CEE FACIAL INJECTABLE MARKET
FIGURE 11 CEE FACIAL INJECTABLE MARKET – MARKET DEVELOPMENT ANALYSIS (ORGANIC VS INORGANIC)
FIGURE 12 NEW PRODUCT DEVELOPMENT, LAUNCH AND APPROVAL IS THE MOST PREFFERED STRATEGY ADOPTED BY THE KEY PLAYERS BETWEEN 2016 AND 2020
FIGURE 13 CEE FACIAL INJECTABLE MARKET – BY PRODUCT
FIGURE 14 CEE DERMAL FILLERS/INJECTABLE IMPLANTS MARKET – BY TYPE
FIGURE 15 CEE HYALURONIC ACID FILLERS MARKET – BY COUNTRY
FIGURE 16 COLLAGEN FILLERS MARKET – BY COUNTRY
FIGURE 17 SYNTHETIC FILLERS MARKET – BY COUNTRY
FIGURE 18 ANTI-AGING/ ANTI-WRINKLE INJECTIONS MARKET – BY TYPE
FIGURE 19 BOTULINUM TOXIN A MARKET – BY COUNTRY
FIGURE 20 POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES MARKET – BY COUNTRY
FIGURE 21 CEE FACIAL INJECTABLE MARKET – BY END USER
FIGURE 22 FACIAL INJECTABLE MARKET IN HOSPITALS – BY COUNTRY
FIGURE 23 FACIAL INJECTABLE MARKET IN DERMATOLOGY CLINICS – BY COUNTRY
FIGURE 24 FACIAL INJECTABLE MARKET IN BEAUTY CLINICS – BY COUNTRY
FIGURE 25 FACIAL INJECTABLE MARKET IN DERMATOLOGY RESEARCH INSTITUTES – BY COUNTRY
FIGURE 26 CEE FACIAL INJECTABLE MARKET - OVERVIEW
FIGURE 27 CEE FACIAL INJECTABLE MARKET – BY COUNTRY
FIGURE 28 POLAND FACIAL INJECTABLE MARKET, OVERVIEW 2020
FIGURE 29 CZECH REPUBLIC FACIAL INJECTABLE MARKET, OVERVIEW 2020
FIGURE 30 BULGARIA FACIAL INJECTABLE MARKET, OVERVIEW 2020
FIGURE 31 CROATIA FACIAL INJECTABLE MARKET, OVERVIEW 2020
FIGURE 32 SLOVAKIA FACIAL INJECTABLE MARKET,OVERVIEW 2020
FIGURE 33 ROMANIA FACIAL INJECTABLE MARKET, OVERVIEW 2020
FIGURE 34 ESTONIA FACIAL INJECTABLE MARKET, OVERVIEW, 2020
FIGURE 35 LATVIA FACIAL INJECTABLE MARKET, OVERVIEW 2020
FIGURE 36 HUNGARY FACIAL INJECTABLE MARKET, OVERVIEW 2020
FIGURE 37 SLOVENIA FACIAL INJECTABLE MARKET, OVERVIEW 2020
FIGURE 38 LITHUANIA FACIAL INJECTABLE MARKET, OVERVIEW 2020
FIGURE 39 ALLERGAN PLC: (COMPANY OVERVIEW)
FIGURE 40 ALLERGAN PLC (FINANCIAL OVERVIEW)
FIGURE 41 ALLERGAN PLC: SWOT ANALYSIS
FIGURE 42 MERZ INC.: (COMPANY OVERVIEW)
FIGURE 43 MERZ INC. (FINANCIAL OVERVIEW)
FIGURE 44 MERZ INC. (SWOT ANALYSIS)
FIGURE 45 GALDERMA LABORATORIES: (COMPANY OVERVIEW)
FIGURE 46 GALDERMA LABORATORIES (SWOT ANALYSIS)
FIGURE 47 COLBAR LIFESCIENCE LTD: (COMPANY OVERVIEW)
FIGURE 48 SANOFI: (COMPANY OVERVIEW)
FIGURE 49 SANOFI: (FINANCIAL OVERVIEW)
FIGURE 50 SANOFI: (SWOT ANALYSIS)
FIGURE 51 ANIKA THERAPEUTICS: (COMPANY OVERVIEW)
FIGURE 52 ANIKA THERAPEUTICS: (FINANCIAL OVERVIEW)
FIGURE 53 ANIKA THERAPEUTICS: (SWOT ANALYSIS)
FIGURE 54 TEOXANE LABORATORIES: (COMPANY OVERVIEW)
FIGURE 55 TEOXANE LABORATORIES: (SWOT ANALYSIS)
FIGURE 56 PROLLELIUM MEDICAL TECHNOLOGIES INC.: (COMPANY OVERVIEW)
FIGURE 57 PROLLELIUM MEDICAL TECHNOLOGIES INC.: (SWOT ANALYSIS)
FIGURE 58 SUNEVA MEDICAL INC.: (COMPANY OVERVIEW)
FIGURE 59 SUNEVA MEDICAL INC.: (SWOT ANALYSIS)
FIGURE 60 ZIMMER BIOMET: (COMPANY OVERVIEW)
FIGURE 61 ZIMMER BIOMET: (FINANCIAL OVERVIEW)
FIGURE 62 ZIMMER BIOMET: (SWOT ANALYSIS)
FIGURE 63 SINCLAIR PHARMA: (COMPANY OVERVIEW)
FIGURE 64 SINCLAIR PHARMA: (SWOT ANALYSIS)
FIGURE 65 SCULPT LUXURY DERMAL FILLERS LTD: (COMPANY OVERVIEW)
FIGURE 66 BIOXIS PHARMACEUTICALS: (COMPANY OVERVIEW)
FIGURE 67 SCIVISION BIOTECH INC: (COMPANY OVERVIEW)
FIGURE 68 SCIVISION BIOTECH INC: (COMPANY OVERVIEW)
Single User (PDF)
3850Multi User (PDF)
5150Enterprise User (PDF)
7650Avail customized purchase options to meet your exact research needs.
Detailed scope covering all the major segments in the market
In line data validations to ensure data precision
Market recommendations supporting decision making processes
Round the clock analyst support to resolve your queries
Up to 15% additional free customization to meet your specific requirements